Sinopharm Group Co. Ltd. (SHTDY) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Sinopharm Group Co. Ltd.

    OTC: SHTDY · Real-Time Price · USD
    11.97
    0.00 (0.03%)
    At close: Oct 03, 2025, 3:58 PM
    11.96
    -0.08%
    After-hours: Oct 02, 2025, 08:00 PM EDT

    Sinopharm Income Statement

    Financials in CNY. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
    Period Ending Jun 30, 2025 Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
    Revenue
    		 286.04B 289.78B 294.73B 295.62B 300.95B 145.77B 261.47B 271.93B 249.12B
    Cost of Revenue
    		 265.27B 267.47B 272.78B 270.38B 277.68B 119.99B 239.81B 248.47B 228.53B
    Gross Profit
    		 20.78B 22.31B 21.94B 25.24B 23.27B 25.78B 21.66B 23.46B 20.59B
    Operating Income
    		 7.14B 7.97B 8.22B 10.38B 9.83B 13.25B 9.51B 11.91B 9.07B
    Interest Income
    		 n/a n/a n/a -778.48M 1.3B 330.33M 1.48B 1.68B 1.48B
    Pretax Income
    		 7.2B 6.4B 7.6B 10.65B 8.87B 5.97B 8B 9.29B 7.72B
    Net Income
    		 3.46B 3.35B 3.7B 4.95B 4.1B 4.83B 3.69B 4.18B 3.58B
    Selling & General & Admin
    		 12.51B 13.19B 12.38B 13.09B 13.69B 7.81B 12.38B 11.9B 11.76B
    Research & Development
    		 123.36M n/a n/a n/a n/a n/a n/a n/a n/a
    Other Expenses
    		 1.01B 1.16B 1.34B 2.12B n/a 129.94B n/a n/a n/a
    Operating Expenses
    		 13.63B 14.35B 13.72B 15.2B 13.1B 137.75B 12.18B 12.5B 11.39B
    Interest Expense
    		 n/a n/a n/a n/a n/a 1.27B n/a n/a n/a
    Selling & Marketing Expenses
    		 7.84B 8.68B 8.48B 9.04B 8.43B 4.8B 7.78B 7.83B 7.61B
    Cost & Expenses
    		 278.9B 281.81B 286.51B 284.12B 290.78B 137.75B 251.99B 260.97B 239.93B
    Income Tax Expense
    		 1.87B 1.88B 1.7B 2.53B 1.97B 1.44B 1.78B 2.25B 1.69B
    Shares Outstanding (Basic)
    		 623.01M 622.62M 624.11M 623.36M 623.36M 623.75M 623.36M 624.13M 624.13M
    Shares Outstanding (Diluted)
    		 623.01M 622.62M 624.11M 623.36M 623.36M 623.75M 623.36M 624.13M 624.13M
    EPS (Basic)
    		 5.55 5.35 5.95 7.95 6.60 7.75 5.95 6.70 5.75
    EPS (Diluted)
    		 5.55 5.35 5.95 7.95 6.60 7.75 5.95 6.70 5.75
    EBITDA
    		 9.93B 10.65B 9.53B 13.5B 10.91B 7.24B 10.55B 12.84B 10.06B
    EBIT
    		 7.7B 9.44B 8.38B 12.49B 9.83B 7.24B 9.51B 11.91B 9.07B
    Depreciation & Amortization
    		 2.23B 1.21B 1.15B 1.01B 1.07B -6.01B 1.04B 927.22M 984.69M

    Add to Watchlist